Donna L. LaVoie
President & CEO
Donna’s efforts combine building the agency’s health and science IR and PR practices, strategic direction, staff growth and core competencies. Under Donna’s leadership, LaVoieHealthScience has become an acknowledged leader in health science strategic communications and recognized as one of the top 30 independent healthcare agencies in the US. The agency has received over 50 awards for its client’s work. She is a regular speaker and has written on a range of industry topics for BIO Innovation Organization (BIO) and more.
A PharmaVoice100 2020 recipient, Donna has been recognized for “moving the needle” and creative approaches to solving complex communications challenges. She spearheaded the agency’s trademarked services, The LHS Immersion® process as well as The LHS Fifteen Slide Presentation, which forms the basis for how to tell your story. In 2019, Donna formed a global strategic alliance with Omnicom Public Relations Group to augment the agency’s services with scale and geographic expansion for client success. Prior to starting LHS, Donna was a practitioner at signature biotech’s such as Genzyme Corporation (Sanofi), Alkermes, Inc. and Millennium (Takeda).
- Novell Inc. (Cambridge Technology Partners), Vice President of Investor Relations
- Senior communications and investor relations roles at several life sciences companies including Ergo Science Corporation, Alkermes, Inc., and part of founding team at Genzyme Corporation (Sanofi)